Search for specific topic by selecting first letters:

Fanconi's anemia

Definition

Fanconi's anemia is an inherited disease that primarily affects the bone marrow, resulting in decreased production of all types of blood cells. The lack of white blood cells predisposes the patient to infections, while the lack of platelets and red blood cells may result in bleeding, and fatigue (anemia), respectively. It is also associated with a broad variety of physical anomalies.

Fanconi's anemia is distinct from Fanconi's syndrome, a rare kidney disorder in which nutrients are lost through the urine.

Causes, incidence, and risk factors

Fanconi's anemia is inherited in an autosomal recessive fashion, thus one copy of an abnormal gene is passed on by each parent. It occurs in all racial and ethnic groups. It is classically diagnosed between 2 and 15 years of age.

The disease is caused by a genetic defect that prevents cells from fixing damaged DNA or removing toxic, oxygen free radicals that damage cells. Patients may be suspected of having the disease if they have particular birth defects or develop decreased blood counts.

Symptoms

This set of physical abnormalities occur in 80% of the cases:

  • Skin pigment change -- darkened areas of the skin, cafe-au-lait spots, vitiligo
  • Short stature
  • Upper limb anomalies -- missing, extra or misshapen thumbs; underdeveloped or absent radius bone in the forearm; anomalies of the hands; abnormalities of the ulna
  • Small testicles, genital changes
  • Other skeletal anomalies -- congenital hip abnormality, scoliosis, spinal or rib malformations, small head
  • Eye/eyelid anomalies
  • Kidney malformations
  • Ear anomalies/deafness
  • Hip, leg, and toe abnormalities
  • Gastrointestinal/cardiopulmonary malformations

Other potential symptoms:

  • Mental retardation
  • Learning disability
  • Low birth weight
  • Failure to thrive
  • An affected sibling

Signs and tests

Common tests performed in evaluating Fanconi's anemia include:

  • CBC (complete blood count) initially demonstrates low platelets (thrombocytopenia), then low neutrophils (a type of white blood cell), and finally low hemoglobin (anemia), which develops over months to years.
  • Bone marrow biopsy.
  • Clastogenic stress-induced chromosomal breakage analysis on blood cells of patients and their siblings to diagnose the disease. In this test, drugs are added to a blood sample to check for abnormal damage to chromosomes.
  • HLA tissue typing on the patient and their family members to determine if any are matching bone-marrow donors.
  • Hand x-ray, and other imaging studies (x-ray, CT scan, MRI) to evaluate any anomalies.
  • Hearing test.
  • Developmental tests.
  • Ultrasound of the kidneys.
  • Amniocentesis or chorionic villous sampling has been used for prenatal diagnosis.

Treatment

If the hematological changes are mild to moderate and the patient does not require transfusions, a period of observation is currently recommended with frequent blood count checks and yearly bone marrow examinations. Observations for the development of secondary malignancies are also performed. In the short term, growth factors (such as erythropoetin, G-CSF, and GM-CSF) can be used to improve blood counts. Other growth factors for platelet stimulation are currently under investigation.

Bone marrow transplantation can cure the blood count problems associated with Fanconi's anemia. A HLA matched sibling is the best donor source, although umbilical cord blood cells and unrelated bone marrow can also be used. This therapy is very effective, and although there are associated toxicities, there has been improvement in the care of Fanconi patients during the transplant. There is approximately a 70% success rate for those patients fortunate enough to have a donor.

Even though a successful bone marrow transplant can cure the bone marrow problems from Fanconi's anemia, patients are at risk for other cancers and must be regularly followed by a physician (see below).

Prior to bone marrow transplantation, androgen therapy (oxymetholone, nandrolone decanoate) combined with low doses of steroids (hydrocortisone, prednisone) was the standard treatment, and this approach is currently used if the patient does not have an appropriate bone marrow donor. Typically, 50-75% of patients initially respond to androgen therapy, however, all patients will rapidly relapse when the drug is stopped. In most cases, these drugs eventually become ineffective.

Symptoms due to low blood counts, such as bleeding, infections, or symptomatic anemia (fatigue, shortness of breath, chest pain, dizziness), are treated with transfusions or antibiotics as needed. Patients with low neutrophil counts, who develop a fever, are usually treated with intravenous antibiotics.

Most patients visit a hematologist, an endocrinologist, and an ophthalmologist regularly. An orthopedist, gynecologist, or nephrologist may be seen as needed.

Expectations (prognosis)

The reported survival of patients with Fanconi's anemia is highly varied, ranging from 2 to 25 years. The prognosis is especially poor if blood counts are low. Survival has likely been improved by the development and refinement of therapies, such as bone marrow transplantation.

Although bone marrow transplantation can restore blood counts, patients with Fanconi's anemia remain predisposed to a variety of cancers (leukemia, myelodysplastic syndrome, liver cancer, and others).

Women with Fanconi's anemia who become pregnant should be watched carefully by a doctor, as they often require transfusions throughout pregnancy. Men with Fanconi's anemia have decreased fertility, although a small number have fathered children.

Prevention

Fanconi's anemia is an inherited disorder, and little can be done to prevent the disease short of genetic counseling for families known to be affected as a result. However, some complications, such as pneumococcal pneumonia, hepatitis, and varicella infections, can be prevented by vaccination.

Additionally, patients should avoid known carcinogens and undergo regular cancer screening to detect malignancies early in their course, should they arise.

Illustrations

Formed elements of blood
Formed elements of blood

Page Content:

Anemia - Fanconi's; FA ; anemia fanconis; fa; fa cup; fa kedah; fa cup final; mei fa; fa cup final ticket; ai fa mo qing shi; fa premier league; 2006 cup fa final; england fa; 2006 cup fa; liverpool fa cup; english fa; fa cup ticket; search fa; fa premiership; washington mutual bank fa; chick fa la; english fa cup; 003399 1 1 au bgc fa lang nbram nbwm size; bo fa; sweet fa; tonic sol fa; fa cup winner; fa cup result; fa 18; ai ep12 fa mo qing shi; chick fa lay; 2006 cup fa final ticket; ai ep16 fa mo qing shi; fa premier; cup fa final liverpool; game fa; http galleries.aebn.net beta3 index.cfm fa gallery genre; 2006 cup fa liverpool; fa cup history; ai ep13 fa mo qing shi; fa ru xue; ai ep15 fa mo qing shi; universal savings bank fa; 2006 cup fa winner; fa mulan; fa jing; fa 18 hornet; england fa merchandise official; fa davis; che tempo che fa; fa 22; cup fa gerrard; hala fa; chick fa lay restaurant; hala fa forum; google.com intl fa; fa deodorant; liu he ba fa; ai ep14 fa mo qing shi; fa 22 raptor; fa mi; fa cup highlight; fa cup live; scottish fa; fa cup soccer; the fa com; cup fa final live; do re mi fa so la ti do; jazzy fa; chou fa jay lyric ru xue; the fa full time; bbw fa; fa cup final result; fa cup.com; santa fa; england fa cup; cup fa final highlight; well fa; fa lyric ru xue; cup fa gerrard steven; fa football; final fa; cup fa final tv; ai ep11 fa mo qing shi; nikon fa; chic fa la; liverpool fa; fa fa; english fa cup final; cup fa gerrard goal steven; fa fa fa fa fa sad song; fa mas; 2006 cup fa liverpool winner; chou fa jay ru xue; do re mi fa sol la si; 003399 1 1 1 au bgc fa lang nbram nbwm prefs size; google.com fa; una voce poco fa; john fa cena; fa cup goal; pak fa; fa tacotel.nl tapes.mpg; che tempo fa